Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD

Clinical trial NCT07773246 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07773246
Sponsor: Korro Bio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urea Cycle Disorders, Inborn Urea Cycle Disorders Ornithine Transcarbamylase (OTC) Deficiency Arginase 1 Deficiency NAGS Deficiency Carbamylphosphate Synthetase I Ornithine Transporter Mitochondrial 1 Argininosuccinate Synthase Argininosuccinate Lyase Deficiency N-acetyl Glutamate - Synthetase Citrin Deficiency

Start date: 2026-09-01
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.